Clinical trial reports

  • Which CROs support European renal cell carcinoma phase 2 & 3 trials most often?
  • Which EU Sites Anchor Phase II–III CKD and Kidney Failure Trials?
  • Which Endpoints Are Measured Most Often in European Phase II & III Head and Neck Cancer Trials?
  • Which EU sites anchor Phase III dermatology trials?
  • Which EU sites dominate Phase II cell therapy trials?
  • Which EU Sites Lead Radiopharmaceutical Phase I–III Trial Participation?
  • Which EU/EEA Sites Lead Ophthalmology Phase II/III Trials?
  • Which CROs Support Prostate Cancer Phase II/III Trials in Europe, and When Are They Most Needed?
  • Are Digital Recruitment Channels Still Underused in European Phase III Breast Cancer Trials?
  • Which Endpoints Are Measured Most Often in European Myelodysplastic Syndrome Phase II & III Trials?
  • Which Endpoints Are Measured Most Often in European Inflammatory Bowel Disease Phase II & III Trials?
  • Which endpoints are most frequently measured in European Phase II and III glioblastoma and glioma clinical trials?